Nisreen Al-Moghrabi

Nisreen Al-Moghrabi is the head of the Cancer Epigenetics section in the department of Molecular Oncology at King Faisal Specialist Hospital and Research Center. For the last 10 years, Dr. Al-Moghrabi has been focusing on investigating the possible use of white blood cells aberrant DNA promoter methylation of different cancer suppressor genes, in addition to circulating microRNAs, as potential biomarkers for the early prediction of cancer predisposition. She has also been investigating the epigenetic therapeutic effects of natural compounds on cancer.

Latest posts by Nisreen Al-Moghrabi (see all)